HER-2 D769Y
|
HER2 Negative Breast Cancer
|
HER-2 D769Y
|
HER2 Negative Breast Cancer
|
neratinib Sensitive: C2 – Inclusion Criteria
|
neratinib Sensitive: C2 – Inclusion Criteria
|
HER-2 D769Y
|
HER2 Negative Breast Cancer
|
HER-2 D769Y
|
HER2 Negative Breast Cancer
|
lapatinib Sensitive: C4 – Case Studies
|
lapatinib Sensitive: C4 – Case Studies
|
HER-2 D769Y
|
LUAD
|
HER-2 D769Y
|
LUAD
|
afatinib + anlotinib Sensitive: C4 – Case Studies
|
afatinib + anlotinib Sensitive: C4 – Case Studies
|